IL2 and hepatocellular carcinoma: Therefore, treatment with PD‐L1 siRNA and IL‐2 pDNA‐loaded TT‐LDCP NPs efficiently silenced the PD‐L1 expression while increased IL‐2 expression in HCC cells, synergistically leading to enhanced infiltration of CD8+ T cells into TME.